COPD Support Discussion Boards Active Users: 276 / Visits Today: 10256
Highest Active Users: 765
COPD Support Discussion Boards
Home | Profile | Register | Active Topics | Members | Search | FAQ
Username:
Password:
Save Password
Forgot your Password?

 All Forums
 Moderated Forums
 COPD Support Newsletters
 COPD Support News Dec 10, 2010
 New Topic  Reply to Topic
 Printer Friendly
Author Previous Topic Topic Next Topic  

Carolyn-Mi
Administrator

608 Posts

Posted - Dec 10 2010 :  08:50:47 AM  Show Profile  Reply with Quote
Volume 10, Issue 53
December 10, 2010


GENERIC MEDICINES FROM INDIA THREATENED
The importation of inexpensive, generic medications from India into the U.S., European Union member nations, and other countries, is under attack by the Anti-Counterfeiting Trade Agreement (ACTA). ACTA is an international effort to stamp out trade in counterfeit goods. In 2010, ACTA member nations reached an "agreement in principle," and began working on the specific wording of the agreement. According to ACTA, counterfeit goods not only include fakes such as knockoff designer handbags and pirated computer software, but also anything that infringes upon "intellectual property rights." The importation of inexpensive generic medications is an intellectual property rights issue. In the U.S., for example, manufacturers of brand name medications hold the intellectual property rights to those medications. They want to preserve their exclusive control over the medications they develop. Generic versions of their medications cannot legally be manufactured or sold in the U.S. without their permission or as long as the patent is active. If their product is protected by U.S. patent laws, and if there is no generic version approved in the U.S., ACTA would require U.S. customs to seize generic versions of those drugs when they enter the U.S. Other countries have their own laws governing intellectual property rights. In India, for example, the drug manufacturing process, not the drug itself, is considered intellectual property. Therefore, if you produce the same drug using a different process, you are not infringing on the rights of the original drug manufacturer. In contrast, the U.S. is less concerned with the manufacturing process. It is more interested in protecting the outcome of the manufacturing process, the drug itself. Simply put, India protects the means (process) by which a drug is produced, whereas the U.S. protects the end product, the drug itself. When it comes to trade, ACTA would like all member nations to follow ACTA’s rules concerning the protection of intellectual property.


When pertaining to generic drugs, ACTA is apparently not as big a news item in the U.S. as it is in India—one of the world's largest exporrters of generic medications. The Indian e-magazine Down to Earth: Science and Environment (part of the Center for Science and Environment) has an article from the exporter's perspective. Entitled "ACTA is Trade Terrorism," this spicy article is an interesting and relevant read for those who rely upon importing inexpensive generic medications from India. Although the article questions U.S. custom officials' ability to differentiate between what medications are allowed and not allowed into the U.S., the writer also quotes a U.S. trade official who says the U.S. will use, "state-of-the-art provisions" to detect counterfeit goods. Unfortunately, the Down to Earth article does not cover the interesting history of the international battle over "intellectual property rights" as it relates to generic medications manufactured in India. The history is an interesting one, and the threat of not being allowed to import unlicensed generic medications from India is not new. For example, the World Trade Organization has been involved in conflicts over issues concerning "intellectual property" of medications for years. In fact, it is speculated that ACTA, to avoid world-wide condemnation and protests, will allow India to continue to manufacture and sell low cost generic drugs to underdeveloped countries, particularly those in Africa fighting AIDS. This has little to do, however, with customs seizing imports in developed countries. To read the Down to Earth article, go to:
http://tinyurl.com/2dmfxr4

Unbiased articles about ACTA are hard to find. Due to the fear that personal computers will be monitored or invaded in the quest to stamp out pirated software and computer related technology, most articles on the Internet have a strong anti-ACTA bias. For information about ACTA, see Wikipedia's description at: You can find it at:
http://tinyurl.com/6eyaqb

ALSO IN THIS ISSUE
- INVACARE QUESTIONS FINANCES OF 34 PERCENT OF COMPETITIVE BID WINNERS
- NATIONAL COUNCIL ON AGING URGES CONGRESS TO EXTEND MEDICARE PROGRAM FOR LOW-INCOME SENIORS
- RETIREES WILL NEED BIG SAVINGS TO FACE FUTURE MEDICAL COSTS
- MORE COPD PATIENTS COULD BENEFIT FROM OXYGEN THERAPY
- CARE AT HOME: A NEW CIVIL RIGHT?
- NEW LUNG DISEASE NETWORK IN THE UK BENEFITS PATIENTS AND ECONOMY
- LIVE CHRISTMAS TREES CAN TRIGGER MOLD ALLERGIES
- BLACK RICE MAY FIGHT INFLAMMATION
- NEW THERAPY FOR COPD CLAIMS TO BE SUPERIOR TO SPIRIVA AND FORADIL
- MISCELLANEOUS
CHARITABLE GIVING: KNOW WHERE YOUR DONATIONS GO!
TAKE A VIRTUAL TOUR OF THE FORBIDDEN CITY
HERE'S A SITE DEDICATED TO FRUGAL LIVING
RELIGIONS OF THE WORLD
GAMES TO KEEP YOU AWAKE WELL PAST YOUR BEDTIME


~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<
SOURCES: News items summarized in The COPD-NEWS are taken from secondary sources believed to be reliable. However, the COPD Family of Services does not verify their accuracy.
~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<


INVACARE QUESTIONS FINANCES OF 34 PERCENT OF COMPETITIVE BID WINNERS
Invacare, the largest manufacturer of home medical products, points out that many of the "winners" in Medicare's competitive bidding process have "questionable financial foundations." Under the new competitive bidding program, the Centers for Medicare Services (CMS) awarded Medicare contracts to 359 of the lowest bidders for services including supplying home and portable oxygen. The first stage of this program will start on January 1, 2010, in 11 areas throughout the U.S. As the industry's largest creditor, Invacare points out that some of the companies awarded contracts already have "holds" on their credit. In fact, some are so far behind in their payments that legal actions are currently being taken against them! Such companies, according to Invacare, might not be able to purchase the equipment needed to fulfill their Medicare contracts. This article in HomeCare, an industry magazine, provides a unique perspective of some of the potential problems of the new competitive bidding process:
http://tinyurl.com/2crvsb4

NATIONAL COUNCIL ON AGING URGES CONGRESS TO EXTEND MEDICARE PROGRAM FOR LOW-INCOME SENIORS
The National Council on Aging (NCOA) is urging Congress to extend the Qualified Individual (QI) Medicare Savings Program before it expires at the end of this year. The program, for low­income Medicare recipientts, pays their Medicare Part B premiums. In addition, qualifying for this plan entitles individuals for financial aid to help pay for their Medicare Part D prescription drug plan. To qualify, individuals must earn between 120 and 135 percent of the federal poverty level. This amounts to between about $13,000 to $14,600 a year. For the NCOA article, visit:
http://tinyurl.com/27a734z
For information on Medicare’s Medical Savings Program, see:
http://tinyurl.com/27vqjmx

RETIREES WILL NEED BIG SAVINGS TO FACE FUTURE MEDICAL COSTS
The Washington D.C. based Employee Benefits Research Institute (a data and research organization that is non-profit and non-partisan) has updated their projections for how much personal savings are needed to cover medical expenses during retirements years. Although prior estimates projected medical costs would go down because of recent healthcare reform initiatives (particularly, better coverage of drugs under Medicare Part D), the institute now projects that a man with median drug expenditure will need about $65,000, and a women, because they live longer, will need about $93,000. The bad news is that the above projected amount of savings would only give individuals a 50 percent chance of having enough savings. For better odds—say, a 90 percent chance of having enough assets——men would need $187,000 and women…hold on…would need $213213,000! Of course, there are other things to consider, and more numbers to spin, so if you have the nerve, you can read more about it at:
http://tinyurl.com/3ykzen4

~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<
COMMERCIAL FREE: We do not accept any paid advertising. Any corporations, products, medicines (prescription or over the counter) mentioned in this newsletter are for informational purposes only and not to be construed as an endorsement or condemnation of same.
~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<


MORE COPD PATIENTS COULD BENEFIT FROM OXYGEN THERAPY
The website 6-minutes, a daily newsletter for Australian doctors, reports on a study that finds many patients ineligible for supplemental oxygen under current criteria could still benefit from oxygen therapy. They conclude that a single daytime measurement of oxygen in the blood may not be the best method of determining who could benefit from oxygen therapy. Researchers find a large number of people are okay during the day, but have oxygen saturations below 90 percent at night. For more information, see:
http://tinyurl.com/23pwmr4

CARE AT HOME: A NEW CIVIL RIGHT?
In 1999, the U.S. Supreme Court ruled in Olmstead vs. L.C. that people with disabilities who live in institutions such as nursing homes, and who have the ability to live at home if they get appropriate care, have a right—a civil right under the Americans with Disabilities Act——to live at home. National Public Radio (NPR) explores this right in the context of other civil rights, and looks at the progress made (or not made) in home services for people with disabilities. This interesting read can be found at:
http://tinyurl.com/26zp4gc

NEW LUNG DISEASE NETWORK IN THE UK BENEFITS PATIENTS AND ECONOMY
Nine centers across the United Kingdom are part of a government program to forge links between the National Health Service, academia, and the life-science industry to find new ways of diagnosing and treating COPD. These nine "Therapeutic Capability Clusters" hold the promise of getting new drugs from the lab to the patient more quickly than the current practice. The clusters will work closely with the pharmaceutical industry, and hopefully, lead to more rapid development of new COPD drugs within the U.K. It is also believed that the speedy development of drugs to treat COPD will be benefit the economy. This University of Nottingham article will explain more:
http://tinyurl.com/29bz6en

~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<
MEDICAL DECISIONS. Your physician should be consulted on all medical decisions. New procedures or drugs should not be started or stopped without such consultation. While we believe that our accumulated experience has value, and a unique perspective, you must accept it for what it is...the work of COPD patients. We vigorously encourage individuals with COPD to take an active part in the management of their disease. They do this through education and by sharing information and thoughts with their primary physician and pulmonologist. However, medical decisions are based on complex medical principles and should be left to the medical practitioner who has been trained to diagnose and advise.
~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<>~<


LIVE CHRISTMAS TREES CAN TRIGGER MOLD ALLERGIES
Bah humbug! Researchers find that the level of mold spores from live Christmas trees grow after the tree is brought indoors. In fact, the mold can increase fivefold during the time the tree insists on taking up residence in your home. In addition, the aroma of a live tree can cause irritation to some people. To learn more, and to explore some solutions to this potential problem, see this 2007 U.S. News and World Report article:
http://tinyurl.com/3dc799

BLACK RICE MAY FIGHT INFLAMMATION
The findings of a study published in the American Chemical Society's Journal of Agricultural and Food Chemistry adds to the list of known benefits from eating black rice bran. Already known to reduce cholesterol, help prevent ulcers and blood clots, and help block the spread of some cancers, researchers now find that black rice bran also fights inflammation. Unrelated studies already indicate that an inflammatory process might underlie the development and progression of COPD. For a review of the black rice study, see:
http://tinyurl.com/2cvydk4
For a discussion of inflammation in COPD, see this Medscape article (you must sign in):
http://tinyurl.com/26hrfnp

NEW THERAPY FOR COPD CLAIMS TO BE SUPERIOR TO SPIRIVA AND FORADIL
Pearl Therapeutics, located in the U.S., announces that its new drug PT003, a combination bronchodilator, provides better bronchodilation than Spiriva and Foradil. PT003, still undergoing trials, uses a metered dose inhaler (MDI), and is proving to be safe and well-tolerated. Studies were conducted on individual with "moderate" to "very severe" COPD. For more information, visit:
http://tinyurl.com/27uaart

**********************************************
JOIN US? Subscription to this Newsletter is free and we hope that it serves your needs. For more Newsletter information, go to: http://copd-support.com/signup-news.html

The Newsletter, like all the other endeavors of the Family of COPD Support Programs, is provided to you by COPD-Support, Inc. a non-profit member organization with IRS designation 501(c)(3). If you would like to be involved and help us provide these programs to the individuals who benefit from them, please consider joining us as a member. Further information is available at:
http://copdsupport.com/membership.html*********************************


MISCELLANEOUS


CHARITABLE GIVING: KNOW WHERE YOUR DONATIONS GO!
Although it is better to give than receive, you still have to be careful when making donations. This Greenopolis article on charitable giving provides you with what you need to know to be sure your donation is going to good use. Don't pass up the link for "Guidestar" towards the end of the article. Guidestar is a website where you can look up charities' IRS 990 forms to see how they really spend your money (for starters, look up the top salaries)! Although the Guidestar site requires registration, the Greenopolis website can be conveniently viewed at:
http://tinyurl.com/2f3xsq9

TAKE A VIRTUAL TOUR OF THE FORBIDDEN CITY
Thanks to a huge grant from IBM, you can take a virtual 3-dimentional tour of China's Forbidden City. You'll have to download the program, so high speed is recommended. In fact, the site itself takes a bit long to open, so be patient. Once you download the software, you'll be able to stroll thought the 178 acres of the palace with your "avatar" (an image representing you), and learn interesting facts as you go. Best of all, it is easy on the feet. Be warned, however, that you'll probably have a hankering for Chinese food after your visit!
http://tinyurl.com/5oljzs

HERE'S A SITE DEDICATED TO FRUGAL LIVING
Frugal: economical; non-wasteful; requiring few resources; entailing little expense, etc. Whether your lifestyle is frugal by choice, or imposed upon you due to limited resources, you'll find this FrugalVillage website has many useful tips:
http://tinyurl.com/o7wap

RELIGIONS OF THE WORLD
December is the month of Hanukkah, Hijra, Bhodi Day, Ashura, Yule/Litha, Christmas, and a day to honor the death of Zarathustra. Yes, holidays for many religions abound this time of year, so there's no better time to take a few minutes to better understand some of the world's greatest religions. This British Broadcasting Corporation website helps you do just that:
http://tinyurl.com/6f8fhf

GAMES TO KEEP YOU AWAKE WELL PAST YOUR BEDTIME
Einstein forgot to mention that time speeds up while playing games online. It must have slipped his mind. Go test this theory yourself at:
http://tinyurl.com/2f9sz29

For comments and questions, or to contact Richard D. Martin, please send your email to: newsletter@COPD-Support.com


Until next Friday,


Richard D. Martin, Editor


Web version of the News: http://copd-support.com/news.htmlArchives at: http://home.ease.lsoft.com/archives/copd-news.html

**********************************************************************
To contact List Management write Management@copd-support.com
Your COPD Support Newsletter is provided only to subscribers.
To see other programs provided in the Family of COPD Support
Programs, examine our web site at http://copd-support.com
To tell your friends how to subscribe to this Newsletter, send them to
http://copd-support.com/signup-news.html

To modify or cancel your subscription to the Newsletter go to:
http://home.ease.lsoft.com/scripts/wa.exe?SUBED1=copd-news&A=1

Please keep in mind that all posts are from COPD patients / caregivers
and not medically trained professionals - consult your medical team
for your personal medical needs.
**********************************************************************

COPD Support
http://www.copd-support.com
  Previous Topic Topic Next Topic  
 New Topic  Reply to Topic
 Printer Friendly
Jump To:
COPD Support Discussion Boards © Copyright COPD-Support, Inc. Go To Top Of Page
Snitz Forums 2000